The data from the CDC's National Immunization Survey estimates that 37.6% of Americans ages 65 and older had gotten a shot of ...

In terms of vaccines, the Berrien County Health Department recommends everyone 6 months and older get this season’s flu ...

Expects to complete enrollment of the 400-participant sentinel cohort for the COVID-19 Phase 2b ... technology against an approved mRNA vaccine.” “On our norovirus program, we received constructive ...

It’s especially important to get this vaccine if you have an underlying medical condition such as obesity, asthma, heart disease, diabetes, emphysema or a suppressed immune system. COVID-19: Everyone ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

Across California, public health and pest control authorities are facing a new reality as the Aedes mosquitoes bring the ...

Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...

Novavax’s COVID-19 vaccine won FDA approval in October 2023 ... of the quarter include the company’s emergency-use ...

Arcturus developed KOSTAIVE®, the first self-amplifying messenger RNA (sa-mRNA) COVID vaccine in the world to be approved. Arcturus has an ongoing ... Arcturus disclaims any intention or obligation to ...

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.